[Immune reaction after penetrating keratoplasty. II. Prevention and therapy].
Pleyer
U
U
Augenklinik, Charité/Virchow-Klinikum, Humboldt-Universität, Berlin.
Rieck
P
P
Ritter
T
T
Hartmann
C
C
D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015948:Keratoplasty, Penetrating / Q000276:immunology*
D007166:Immunosuppressive Agents